Small biotech firms quicker to 'latch onto' AI than big ones, says Tencent Healthcare President

Big companies aren't winning at AI. Smaller ones are. That's what Tencent's healthcare president just told Reuters — and it should shift how you think about where you stand right now. You're not beh

Big companies aren't winning at AI. Smaller ones are.

That's what Tencent's healthcare president just told Reuters — and it should shift how you think about where you stand right now.

You're not behind. You're actually positioned better than you realize.

Here's why that matters: Large organizations move slowly. Approval chains, legacy systems, politics. Small business owners can test something Tuesday and decide by Friday if it works. That's an advantage the big players would pay for.

The businesses getting real AI wins aren't the ones with the biggest budgets. They're the ones who pick one specific problem, find one tool that addresses it, and run a small, low-risk test. No full rollout. No six-month project. Just a focused experiment with a clear success measure.

That's the move. Not a platform. Not a transformation. One problem, one tool, 30 days to see if it earns its keep.

If you've already bought a tool that collects dust — you're not alone, and it doesn't mean AI won't work for you. It usually means the wrong problem got matched to the wrong solution.

Start with the problem, not the product.

What's one repetitive task in your business that quietly drains time every single week?

#AIStrategy #SmallBusiness #BusinessGrowth #AIImplementation

Original Source

Small biotech firms "latch onto" AI more quickly than bigger firms, the head of Chinese tech ​giant Tencent's healthcare division said on Thursday ...